Gate2Brain
Barcelona · Founded 2020
About Gate2Brain
Gate2Brain is an early-stage biotech company launched to improve drug delivery across biological barriers through the use of a radically innovative peptide-based patented technology. Its technology aims to transport drugs to the brain, increasing the efficiency and reducing the side effects of treatments for brain diseases.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.6M
- Last round: Grant (Oct 2022)
- Website: https://www.gate2brain.com
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/gate2brain-513 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.